Souders Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Buy
1,056
+137
+15% +$74.3K 0.06% 140
2025
Q4
$533K Buy
919
+26
+3% +$14.7K 0.06% 130
2025
Q3
$433K Buy
893
+288
+48% +$134K 0.05% 140
2025
Q2
$245K Buy
+605
New +$253K 0.03% 182
2023
Q4
Sell
-1,647
Closed -$833K 158
2023
Q3
$833K Sell
1,647
-50
-3% -$26.6K 0.16% 92
2023
Q2
$885K Buy
1,697
+165
+11% +$89K 0.17% 86
2023
Q1
$883K Sell
1,532
-31
-2% -$17.5K 0.19% 87
2022
Q4
$860K Sell
1,563
-42
-3% -$22.3K 0.2% 87
2022
Q3
$814K Buy
1,605
+19
+1% +$10.6K 0.22% 83
2022
Q2
$862K Buy
1,586
+1,240
+358% +$683K 0.25% 75
2022
Q1
$205K Sell
346
-10
-3% -$5.74K 0.06% 140
2021
Q4
$238K Sell
356
-4
-1% -$2.5K 0.07% 127
2021
Q3
$206K Buy
+360
New +$198K 0.07% 130

Other funds holding TMO

Souders Financial Advisors's TMO Position: Q1 2026 in Review

Souders Financial Advisors increased its Thermo Fisher Scientific (TMO) stake by 15% in Q1 2026, buying an estimated $74.3K and bringing the position to 1,056 shares worth $519K. The position accounts for 0.06% of the portfolio, ranked #140.

Souders Financial Advisors first reported a position in TMO in Q3 2021 and has held it in 13 quarters since. The position peaked at $885K in Q2 2023. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Souders Financial Advisors held 1,056 shares of Thermo Fisher Scientific worth $519K as of Q1 2026.
  • Souders Financial Advisors bought 137 Thermo Fisher Scientific shares in Q1 2026, an estimated $74.3K.
  • Thermo Fisher Scientific made up 0.06% of Souders Financial Advisors's portfolio in Q1 2026, its #140 holding.
  • Souders Financial Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 13 quarters since.
  • Souders Financial Advisors's Thermo Fisher Scientific position peaked at $885K in Q2 2023.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Souders Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.